デフォルト表紙
市場調査レポート
商品コード
1003535

世界の皮膚炎市場の分析(2021年):新型コロナウイルス感染症(COVID-19)の影響と回復過程(2030年まで)

Dermatitis Global Market Report 2021: COVID 19 Impact and Recovery to 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
世界の皮膚炎市場の分析(2021年):新型コロナウイルス感染症(COVID-19)の影響と回復過程(2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の皮膚炎治療薬市場について調査し、市場の概要、医薬品クラス・流通チャネル・投与経路・用途・地域別の市場規模の推移と予測、新型コロナウイルス感染症(COVID-19)の市場への影響、市場成長の推進要因および阻害要因の分析、治療薬パイプラインの分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 新型コロナウイルス感染症(COVID-19)の影響

第5章 市場規模と成長

  • 世界の皮膚炎治療薬市場(実績値)
    • 市場の推進要因
    • 市場の阻害要因
  • 世界の皮膚炎治療薬(予測値)
    • 市場の推進要因
    • 市場の阻害要因

第6章 皮膚炎治療薬市場:セグメント別

  • 市場区分:医薬品クラス別(実績値・予測値)
    • コルチコステロイド
    • エモリエント/保湿剤
    • 抗ヒスタミン薬
    • カルシニューリン阻害剤
    • 抗生物質
    • 免疫調節剤
    • インターロイキン阻害剤
  • 市場区分:流通チャネル別(実績値・予測値)
    • 病院
    • 小売薬局
    • ドラッグストア
    • オンライン薬局・メールオーダー薬局
  • 市場区分:投与経路別(実績値・予測値)
    • 局所
    • 口腔
    • 注射
  • 市場区分:用途別(実績値・予測値)
    • がん
    • 血液疾患
    • 慢性疾患
    • 感染症

第7章 皮膚炎治療薬市場:地域・国別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:国別(実績値・予測値)

第8章 アジア太平洋地域の皮膚炎治療薬市場

  • 市場概要
  • 地域/市場情報・COVID-19の影響・政府イニシアチブ・規制・法人税構造・投資・主要企業など
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第9章 中国の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第10章 インドの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第11章 日本の皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第12章 オーストラリアの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第13章 インドネシアの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第14章 韓国の皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第15章 西欧の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第16章 英国の皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第17章 ドイツの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第18章 フランスの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第19章 東欧の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第20章 ロシアの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第21章 北米の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第22章 米国の皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第23章 南米の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第24章 ブラジルの皮膚炎治療薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第25章 中東の皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第26章 アフリカの皮膚炎治療薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:流通チャネル別(実績値・予測値)

第27章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • LEO Pharma A/S
    • Novartis AG
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Sanofi S.A.

第28章 皮膚炎治療薬パイプライン分析

第29章 主な合併・買収

第30章 将来の見通しと潜在性の分析

第31章 付録

目次

“Dermatitis Global Market Report 2021: COVID 19 Impact and Recovery to 2030 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global dermatitis drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the dermatitis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Dermatitis Drugs Market Global Report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug Class: Corticosteroids; Emollients/Moisturizers; Antihistamines; Calcineurin Inhibitors; Antibiotics; Immunomodulators; Interleukin Inhibitors 2) By Distribution Channel: Hospital; Retail Pharmacies; Drug Stores; Online Or Mail Pharmacies 3) By Route Of Application: Topical; Oral; Injectable 4) By Application: Cancer; Blood Disorders; Chronic Diseases; Infectious Diseases

Companies Mentioned: LEO Pharma A/S; Novartis AG; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Sanofi S.A.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Dermatitis Drugs Market Characteristics

3. Dermatitis Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Dermatitis Drugs

5. Dermatitis Drugs Market Size And Growth

  • 5.1. Global Dermatitis Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Dermatitis Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Dermatitis Drugs Market Segmentation

  • 6.1. Global Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Corticosteroids
  • Emollients/Moisturizers
  • Antihistamines
  • Calcineurin Inhibitors
  • Antibiotics
  • Immunomodulators
  • Interleukin Inhibitors
  • 6.2. Global Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Retail Pharmacies
  • Drug Stores
  • Online Or Mail Pharmacies
  • 6.3. Global Dermatitis Drugs Market, Segmentation By Route Of Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Topical
  • Oral
  • Injectable
  • 6.4. Global Dermatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Blood Disorders
  • Chronic Diseases
  • Infectious Diseases

7. Dermatitis Drugs Market Regional And Country Analysis

  • 7.1. Global Dermatitis Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Dermatitis Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Dermatitis Drugs Market

  • 8.1. Asia-Pacific Dermatitis Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Dermatitis Drugs Market

  • 9.1. China Dermatitis Drugs Market Overview
  • 9.2. China Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Dermatitis Drugs Market

  • 10.1. India Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Dermatitis Drugs Market

  • 11.1. Japan Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Dermatitis Drugs Market

  • 12.1. Australia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Dermatitis Drugs Market

  • 13.1. Indonesia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Dermatitis Drugs Market

  • 14.1. South Korea Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Dermatitis Drugs Market

  • 15.1. Western Europe Dermatitis Drugs Market Overview
  • 15.2. Western Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Dermatitis Drugs Market

  • 16.1. UK Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Dermatitis Drugs Market

  • 17.1. Germany Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Dermatitis Drugs Market

  • 18.4. France Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Dermatitis Drugs Market

  • 19.1. Eastern Europe Dermatitis Drugs Market Overview
  • 19.2. Eastern Europe Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Dermatitis Drugs Market

  • 20.1. Russia Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Dermatitis Drugs Market

  • 21.1. North America Dermatitis Drugs Market Overview
  • 21.2. North America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Dermatitis Drugs Market

  • 22.1. USA Dermatitis Drugs Market Overview
  • 22.2. USA Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Dermatitis Drugs Market

  • 23.1. South America Dermatitis Drugs Market Overview
  • 23.2. South America Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Dermatitis Drugs Market

  • 24.1. Brazil Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Dermatitis Drugs Market

  • 25.1. Middle East Dermatitis Drugs Market Overview
  • 25.2. Middle East Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Dermatitis Drugs Market

  • 26.1. Africa Dermatitis Drugs Market Overview
  • 26.2. Africa Dermatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Dermatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Dermatitis Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Dermatitis Drugs Market Competitive Landscape
  • 27.2. Dermatitis Drugs Market Company Profiles
    • 27.2.1. LEO Pharma A/S
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Pfizer Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Regeneron Pharmaceuticals Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sanofi S.A.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Dermatitis Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Dermatitis Drugs Market

30. Dermatitis Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer